Windlas Biotech - Quaterly Results

08 Feb 2023 Evaluate
The quarter ended December 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1197.04 millions.A humble growth in net profit of 10.50% reported in the quarter ended December 2022 to Rs. 91.88  millions from Rs. 83.15 millions.Operating profit surged to 161.11 millions from the corresponding previous quarter of 148.36 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1197.04 1175.91 1.80 3723.70 3437.99 8.31 4659.30 4276.02 8.96
Other Income 21.62 17.93 20.58 76.31 37.01 106.19 67.06 30.94 116.74
PBIDT 161.11 148.36 8.59 514.31 423.11 21.55 596.01 577.86 3.14
Interest 1.57 2.11 -25.59 6.22 11.29 -44.91 14.17 12.90 9.84
PBDT 159.54 146.25 9.09 508.09 411.82 23.38 581.84 241.45 140.98
Depreciation 31.35 31.45 -0.32 87.96 92.45 -4.86 121.47 129.65 -6.31
PBT 128.19 114.80 11.66 420.13 319.37 31.55 460.37 111.80 311.78
TAX 36.31 31.65 14.72 108.16 86.09 25.64 74.76 61.70 21.17
Deferred Tax 8.65 4.12 109.95 6.75 1.93 249.74 -26.57 13.28 -300.08
PAT 91.88 83.15 10.50 311.97 233.28 33.73 385.61 50.10 669.68
Equity 107.21 108.97 -1.62 108.97 108.97 0.00 108.97 64.11 69.97
PBIDTM(%) 13.46 12.62 6.68 13.81 12.31 12.23 12.79 13.51 -5.34

Windlas Biotech Share Price

966.75 74.25 (8.32%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...